UNSPSC 51281624: Streptomycin

This classification denotes an aminoglycoside antibiotic with the molecular formula C21H39N7O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y45QSO73OB, chemically known as 2,4-diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-o-(2-deoxy-2-methylamino-alpha-l-glucopyranosyl)-3-c-formyl-beta-l-lyxopentanofuranoside but generally known as streptomycin, which bears US NIH Compound Identifier 5999.

UNSPSC 51281624 Streptomycin is a Commodity code that nominally identifies a specific antibiotic, but recent state and local solicitations tagged with this code show little activity aligned with that scope. The opportunities posted under the code address pharmaceuticals and medical supplies broadly—including naloxone, safe drug deactivation systems, first aid and rescue medical consumables, and generic multi-source pharmaceuticals through cooperative purchasing—rather than streptomycin specifically. The issuing bodies include county health departments, city fire rescue divisions, state health and human services agencies, and multistate cooperative purchasing alliances. The mismatch between the code's nominal scope and the actual work being solicited suggests either tagging inconsistency in source systems or the code's use as a catch-all pharmaceutical category within individual jurisdictions' classification schemes.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida released IFB 60459723LAS on June 30, 2026 (due July 26, 2023—note date inconsistency in source) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The City of Tampa released IFB 26P00145 on March 25, 2026 (due March 13, 2026) for 169 line items of medical and first aid supplies including respiratory equipment, electrodes, and airway devices for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises (SLBEs) including a 5 percent bid discount. The Minnesota Department of Administration's MMCAP cooperative purchasing vehicle issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities, with pricing weighted 75 percent and award effective July 1, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 as an exploratory market-intelligence tool regarding direct-to-manufacturer prescription programs, with no formal award timeline or budget identified.